Vycor Medical Inc. (VYCO) 2.3900 $VYCO Vycor Medical,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vycor Medical Inc. (VYCO) 2.3900 $VYCO

Vycor Medical, Inc. President David Cantor Interviewed on Clear Channel's "The Traders Network Show"
Marketwire - Fri Mar 14, 7:55AM CDT
"The Traders Network Show" broadcasted live from Clear Channel Business Talk Radio DFW 1190 AM KFXR is proud to announce the interview recap of special guest President, David Cantor of Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products.

Vycor Medical, Inc. President David Cantor to Be Interviewed Today on Clear Channel Business Talk Radio DFW1190AM
Marketwire - Thu Jan 23, 6:15AM CST
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, announced today that President David Cantor will interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network.

Vycor's NovaVision Unit Announces the Commercial Release of NeuroEyeCoach(TM) -- A Novel Saccadic Eye Training Therapy
Marketwire - Thu Jan 23, 6:00AM CST
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, announced today that its wholly-owned subsidiary, NovaVision has launched the first commercial release of its new saccadic eye training therapy which will be marketed in the U.S. as NeuroEyeCoach(TM). The therapy is now available through the web site www.NeuroEyeCoach.com.

Vycor's NovaVision(R) Vision Restoration Therapy Awarded New Patent
Marketwire - Thu Oct 31, 7:31AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, announced today it has been granted Australian patent # 2007277139 for its NovaVision(R) vision restoration technology. The new patent brings Vycor's total worldwide patent portfolio to 37 granted and 18 pending.

Vycor Medical Announces Planned Launch of First Commercially Available Internet-Based, Direct to the Patient Saccadic Eye Training Program
Marketwire - Tue Oct 15, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today its wholly-owned NovaVision subsidiary plans to launch a new "direct to the patient" saccadic eye training program to be marketed as NeuroEyeCoach(TM). The proprietary Internet-based program is expected to be commercially available by year-end 2013. Additionally, NeuroEyeCoach(TM) will be available in an institutional version designed for use at rehabilitation and medical centers.

Two Investment Opportunities in One Medical Device Company
ACCESSWIRE - Tue Jun 11, 11:15AM CDT
Vycor Medical (VYCO): A Buy One Get One Free Opportunity

Medical Device Maker Adds Patent for Vision Restoration Therapy
ACCESSWIRE - Tue Jun 04, 11:00AM CDT
Vycor Medical Inc. (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, has been significantly strengthening its patent portfolio over the past months. This week, the Company announced a new patent on its NovaVision® Vision Restoration Therapy (VRT™), bringing the total number of issued patents for NovaVision to 30 with nine pending.

Vycor's NovaVision(R) Unit Awarded Its 30th Patent
Marketwire - Mon Jun 03, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, announced today it has been granted Japanese patent #JP5068770 for its NovaVision(R) technology. The patent covers methods for performing vision therapy by stimulating regions of the patient's field of vision that are technically "blind," but may still respond positively to repeated stimulus to eventually improve or recover vision in the blind field.

Vycor Issued Strategically Significant U.S. Patent for Its ViewSite(TM) Brain Access System (VBAS)
Marketwire - Wed May 29, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, announced that U.S. patent #12/545719, which relates to its ViewSite(TM) Brain Access System ("VBAS"), has been issued.

Innovation Marks Medical Device and Therapy Provider as Company to Watch
ACCESSWIRE - Tue May 28, 10:02AM CDT
Vycor Medical (VYCO) Poised to Become a Standard of Care in Neurosurgical Retraction and Neuro Visual Therapy

The Ohio State University Commences Key Comparative Study of Vycor's Patented ViewSite(TM) Brain Access System (VBAS)
Marketwire - Mon May 20, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a medical device company with a suite of FDA approved products, announced today that the Minimally Invasive Cranial Surgery Program at the Ohio State University (Columbus, OH) has commenced an animal study to evaluate a comparison of tissue damage when using Vycor's patented ViewSite(TM) Brain Access System ("VBAS") as compared to an open resection technique (using standard "blade retractors").

Vycor Announces Addition to Board of Directors
Marketwire - Fri May 03, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today that it is adding to the expertise on its board of directors with the appointment of Lowell Rush as independent director and Chairman of a newly-formed Audit Committee. At the same time Heather Vinas, who has remained on the Board since stepping down as President in May 2010, will depart the Board.

Vycor Develops New Device Targeted at the Pediatric Market
Marketwire - Wed May 01, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today that it has finalized the design prototypes of two new product variations of its existing VBAS product suite to be developed specifically for endoscopic work within the ventricles of the brain. Initially this device will be targeted at the pediatric market. The product was developed in close collaboration with a leading pediatric neurosurgeon. It is anticipated that the new products will be available commercially by the end of the year.

Vycor Adds Two Patents for Its New Spinal ViewSite(TM) Cervical Access System
Marketwire - Thu Apr 25, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today it has secured two new patents (2008-518369 and 11/993280) covering its Spinal ViewSite(TM) Cervical Access System (VCAS). The addition of these patents brings Vycor's total patent portfolio to 34 issued and 21 pending. The Company's Vycor Medical division now has 5 issued patents and 11 patents pending, and its NovaVision unit now has 29 issued patents and 10 patents pending.

Vycor Launches New Extension Arm for Its Patented ViewSite(TM) Brain Access System (VBAS)
Marketwire - Mon Apr 15, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today that it has finalized the production and the U.S. commercial launch of an extension arm for its existing ViewSite(TM) Brain Access System ("VBAS") product range. It is currently anticipated that the extension arm will be available in Europe by the end of April.

Vycor Management Outlines Four Pronged Growth Strategy for Its Patented ViewSite(TM) Brain Access System (VBAS)
Marketwire - Thu Apr 04, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) outlined today its multi-pronged strategy to continue to drive adoption for its Vycor Medical division's ViewSite(TM) Brain Access System ("VBAS").

Vycor Issued Hong Kong Patent for Its VBAS Minimally Invasive Brain Access System
Marketwire - Mon Mar 25, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced it has been issued patent number 10106385.8 for its ViewSite(TM) Brain Access System ("VBAS") for the Hong Kong market. Vycor has a distribution agreement in place with Devon Medical which covers Hong Kong and China.

Hospital Acceptance of Vycor's Patented VBAS Minimally Invasive Neurosurgical Device Continues to Accelerate
Marketwire - Wed Mar 13, 7:30AM CDT
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that it continues to experience an increase in the number of hospitals where its patented ViewSite(TM) Brain Access System(R) ("VBAS") device has been approved for use. VBAS is now approved in over 100 hospitals in the U.S. and the number continues to grow. To date, more than 4,000 surgeries have been performed utilizing VBAS.

Vycor Medical, Inc. Announces Management Change
Marketwire - Fri Dec 21, 4:00PM CST
Vycor Medical, Inc. ("Vycor" or "Company") (OTCBB: VYCO) announced today that Richard Denness will resign as the Company's CEO effective December 31, 2012, and as a member of the Board of Directors effective immediately. Mr. Denness will remain as a consultant to the Company during a transition period. The Board will seek to appoint a successor CEO in due course.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tronox Pushes Back on Creditor Restructuring Chatter Firmly

Updated Category News Views 115

A Creditor Rumor Is Not a Restructuring Plan Two creditor groups hiring law firms can make a stock chart look like it stepped on a rake, but it is not the same thing as a debt workout. That distinction is the whole point of Tronox Holdings' November 18 update. A November 17 Wall Street Journal report said two groups of creditors had retained firms described as...

Continue Reading
Schloss Johannisberg Leads 2026 Global Vineyard List

Updated Category News Views 106

A 1,200-year-old riesling estate just beat the world at being memorable. Schloss Johannisberg in Germany’s Rheingau has taken No. 1 in The 50 Best Vineyards 2026, moving up from No. 2 last year and also claiming Best Vineyard in Europe. For anyone watching the wine business from the outside, this is not really a story about one bottle edging out another. It is a...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 127

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading
BVM's Brookfield Headquarters Move Tests Growth Ambition

Updated Category News Views 119

A bigger office is rarely the exciting part of a growth story, yet it can reveal whether the machinery underneath is actually running hot. Best Version Media has moved its headquarters from Janacek Court to 15800 W. Bluemound Road, Suite 400, in Brookfield, Wisconsin, citing room for recent hires, future recruitment and closer collaboration across its print and digital...

Continue Reading
Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 98

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
Trip.com Sets December 1 Date for Third-Quarter Results

Updated Category News Views 17

December’s first after-hours session will put Trip.com Group back under the market’s microscope, whether anybody is ready or not. The company says it will report results for the three months ended September 30, 2026 after the U.S. market closes on Tuesday, December 1. That is the whole hard-news payload for now: a reporting date, a call time, and no numbers to get...

Continue Reading
Tongwei's 846 MW Romania Deal Tests Solar Supply Scale

Updated Category News Views 5

Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...

Continue Reading
SHIFTAIon Puts Governance at Center of AI Migration

Updated Category News Views 69

Legacy code is where grand AI promises usually go to get mugged by reality. ACL Digital’s new SHIFTAIon platform is taking a sensible swing at that ugly problem: not merely generating code faster, but putting discovery, architecture decisions, testing, security checks, reviewer signoffs, and reporting into one controlled modernization process. That distinction matters....

Continue Reading
Banks Face a Choice: Retreat or Fund Climate Resilience

Updated Category News Views 26

A flooded field can turn a prudent loan book into a social retreat overnight. That is the uncomfortable nerve in the Global Alliance for Banking on Values paper unveiled at COP31 in Antalya on November 19, 2026. Banks have become very practiced at mapping physical climate exposure, raising prices, tightening standards and stepping away. Fine, risk discipline matters. But...

Continue Reading
Barcelona Housing Summit Puts Affordability on the Map

Updated Category News Views 12

A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Share Buybacks and Voting Rights Dynamics

Updated Category News Views 130

Overview of Share Buybacks In recent financial news, Octopus AIM VCT plc has engaged in a strategic move by purchasing its own shares. This action is often a signal of confidence in the company's future and an investment in its own value. Details of the Transaction The company has recently announced the acquisition of 590,908 ordinary shares at a price of 47.27p each....

Continue Reading
Kojamo's Financial Report Highlights: Growth and Outlook

Updated Category News Views 186

Overview of Kojamo plc's Financial Performance Kojamo plc has recently published its financial report, highlighting significant changes and developments in their occupancy rates and revenues for the first half of the fiscal year. This report is particularly important for investors and stakeholders keen on understanding the company's financial health. Financial Highlights...

Continue Reading
Silicom Ltd. Partners with U.S. Firm for Edge Networking Growth

Updated Category News Views 167

Silicom Ltd. Partners with Provider for Edge Networking Solutions - $1 million annual run rate with potential for a significant multi-million-dollar scale-up - Silicom Ltd. (NASDAQ: SILC), a recognized leader in networking and data infrastructure solutions, has announced an exciting collaboration with a U.S.-based provider specializing in Edge networking solutions...

Continue Reading
Understanding the Ongoing Securities Case Against Five Below, Inc.

Updated Category News Views 120

Overview of the Class Action Lawsuit Against Five Below, Inc. As an investor, it's essential to stay informed about your rights, especially with ongoing legal matters. Currently, a notable class action lawsuit is underway involving Five Below, Inc. (NASDAQ: FIVE), which is particularly relevant for its shareholders. Class Period Details The allegations pertain to the time...

Continue Reading
Worthington Enterprises to Boost Portfolio with LSI Group Buyout

Updated Category News Views 169

Worthington Enterprises Expands Its Portfolio with Major Acquisition Worthington Enterprises Inc. (NYSE: WOR), renowned for its innovative designs and manufacturing prowess, has officially announced its intent to acquire LSI Group, LLC. This major acquisition positions Worthington Enterprises to enhance its offerings and market presence in the metal roofing sector....

Continue Reading